gold has been researched along with 1,3,4-oxadiazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaves, JDS; Corrêa, CC; de Almeida, MV; de J Franco, CH; Fontes, APS; Francisco, TM; Monte-Neto, RL; Murta, SMF; Silva, H; Tunes, LG | 1 |
| Costa, DS; de Almeida, MV; Espinosa, AV; Grazul, RM; Monte-Neto, RLD; Silva, H; Tunes, LG | 1 |
2 other study(ies) available for gold and 1,3,4-oxadiazole
| Article | Year |
|---|---|
Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Topics: Antimony; Antineoplastic Agents; Antiprotozoal Agents; Cell Line, Tumor; Drug Design; Drug Resistance; Gold; Humans; Leishmania infantum; Organogold Compounds; Oxadiazoles; Phosphines | 2017 |
Anticancer and antileishmanial in vitro activity of gold(I) complexes with 1,3,4-oxadiazole-2(3H)-thione ligands derived from δ-D-gluconolactone.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Cell Line; Cell Survival; Coordination Complexes; Cyclization; Gluconates; Gold; Humans; Lactones; Leishmania; Ligands; Mice; Oxadiazoles; Structure-Activity Relationship; Thiones | 2021 |